05February

Novo Nordisk files annual report with the SEC ... Read more

01February

Novo Nordisk's operating profit decreased by 4% in Danish kroner and increased b ... Read more

17December

Staten Biotechnology B.V. and Novo Nordisk A/S announce collaboration to develop ... Read more

23November

Oral semaglutide demonstrates favourable cardiovascular safety profile and signi ... Read more

13February

Trading in Novo Nordisk shares by board members, executives and associated perso ... Read more

11February

Novo Nordisk A/S - Share repurchase programme ... Read more

04February

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives an ... Read more

01February

Novo Nordisk's operating profit decreased by 4% in Danish kroner and increased b ... Read more

21March

Annual General Meeting, Copenhagen

03May

Financial statement for the first three months of 2019,

09August

Financial statement for the first six months of 2019,

01November

Financial statement for the first nine months of 2019,

 

 

 

Investors

 
Share information


Take an advanced view of the Novo Nordisk share

 
Annual Report 2018 


Click here to find further information

 
Full year 2018 financial results


Novo Nordisk at a glance


Private shareholders


See relevant content for private investors



IR material


Download relevant Investor Relations material



Contacts



Subscriptions


Sign up to receive company announcements.


ADA investor and analyst event